Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 37 entries
Sorted by: Best Match Show Resources per page
Illness perceptions of Israeli hospitalized patients with acute coronary syndrome.

Nursing in critical care

Ganz FD, Raanan O, Shafir G, Levy D, Klempfner R, Beigel R, Iakobishvili Z.
PMID: 33780082
Nurs Crit Care. 2021 Mar 29; doi: 10.1111/nicc.12616. Epub 2021 Mar 29.

BACKGROUND: Illness perceptions (IPs) can affect cardiac health behaviours and outcomes.AIMS AND OBJECTIVES: To investigate IPs among patients hospitalized with acute coronary syndrome (ACS).DESIGN: Longitudinal survey.METHODS: The ACS Israel Study is a national, biennial registry, enrolling all patients with...

Cite
Ganz FD, Raanan O, Shafir G, et al. Illness perceptions of Israeli hospitalized patients with acute coronary syndrome. Nurs Crit Care. 2021;doi: 10.1111/nicc.12616.
Ganz, F. D., Raanan, O., Shafir, G., Levy, D., Klempfner, R., Beigel, R., & Iakobishvili, Z. (2021). Illness perceptions of Israeli hospitalized patients with acute coronary syndrome. Nursing in critical care, . https://doi.org/10.1111/nicc.12616
Ganz, Freda DeKeyser, et al. "Illness perceptions of Israeli hospitalized patients with acute coronary syndrome." Nursing in critical care vol. (2021). doi: https://doi.org/10.1111/nicc.12616
Ganz FD, Raanan O, Shafir G, Levy D, Klempfner R, Beigel R, Iakobishvili Z. Illness perceptions of Israeli hospitalized patients with acute coronary syndrome. Nurs Crit Care. 2021 Mar 29; doi: 10.1111/nicc.12616. Epub 2021 Mar 29. PMID: 33780082.
Copy Download .nbib Format: NLM
Disease evolution and risk-based disease trajectories in congestive heart failure patients.

Journal of biomedical informatics

Roni RG, Tsipi H, Ofir BA, Nir S, Robert K.
PMID: 34875386
J Biomed Inform. 2022 Jan;125:103949. doi: 10.1016/j.jbi.2021.103949. Epub 2021 Dec 05.

Congestive Heart Failure (CHF) is among the most prevalent chronic diseases worldwide, and is commonly associated with comorbidities and complex health conditions. Consequently, CHF patients are typically hospitalized frequently, and are at a high risk of premature death. Early...

Cite
Roni RG, Tsipi H, Ofir BA, et al. Disease evolution and risk-based disease trajectories in congestive heart failure patients. J Biomed Inform. 2021;125:103949doi: 10.1016/j.jbi.2021.103949.
Roni, R. G., Tsipi, H., Ofir, B. A., Nir, S., & Robert, K. (2022). Disease evolution and risk-based disease trajectories in congestive heart failure patients. Journal of biomedical informatics, 125103949. https://doi.org/10.1016/j.jbi.2021.103949
Roni, Ramon-Gonen, et al. "Disease evolution and risk-based disease trajectories in congestive heart failure patients." Journal of biomedical informatics vol. 125 (2022): 103949. doi: https://doi.org/10.1016/j.jbi.2021.103949
Roni RG, Tsipi H, Ofir BA, Nir S, Robert K. Disease evolution and risk-based disease trajectories in congestive heart failure patients. J Biomed Inform. 2022 Jan;125:103949. doi: 10.1016/j.jbi.2021.103949. Epub 2021 Dec 05. PMID: 34875386.
Copy Download .nbib Format: NLM
Association of Polycythemia with Outcomes of Acute Coronary Syndrome.

Cardiology

Marcus G, Farkouh ME, Minha S, Fuchs S, Kalmanovich E, Beigel R, Iakobishvili Z, Klempfner R, Matezky S, Marcus R.
PMID: 34718235
Cardiology. 2021;146(6):720-727. doi: 10.1159/000519468. Epub 2021 Oct 29.

BACKGROUND: Polycythemia has not been extensively studied for its impact on acute coronary syndrome (ACS) outcomes. A previous study reported only 30-day outcomes to be worse in these patients.METHODS: Data from the ACS Israeli survey between 2000 and 2018...

Cite
Marcus G, Farkouh ME, Minha S, et al. Association of Polycythemia with Outcomes of Acute Coronary Syndrome. Cardiology. 2021;146(6):720-727doi: 10.1159/000519468.
Marcus, G., Farkouh, M. E., Minha, S., Fuchs, S., Kalmanovich, E., Beigel, R., Iakobishvili, Z., Klempfner, R., Matezky, S., & Marcus, R. (2021). Association of Polycythemia with Outcomes of Acute Coronary Syndrome. Cardiology, 146(6), 720-727. https://doi.org/10.1159/000519468
Marcus, Gil, et al. "Association of Polycythemia with Outcomes of Acute Coronary Syndrome." Cardiology vol. 146,6 (2021): 720-727. doi: https://doi.org/10.1159/000519468
Marcus G, Farkouh ME, Minha S, Fuchs S, Kalmanovich E, Beigel R, Iakobishvili Z, Klempfner R, Matezky S, Marcus R. Association of Polycythemia with Outcomes of Acute Coronary Syndrome. Cardiology. 2021;146(6):720-727. doi: 10.1159/000519468. Epub 2021 Oct 29. PMID: 34718235.
Copy Download .nbib Format: NLM
Midterm outcomes of patients with multivessel disease treated at centers with and without on-site cardiac surgery services.

The Journal of thoracic and cardiovascular surgery

Ram E, Raanani E, Klempfner R, Peled Y, Sternik L, Segev A.
PMID: 32711976
J Thorac Cardiovasc Surg. 2020 May 30; doi: 10.1016/j.jtcvs.2020.04.170. Epub 2020 May 30.

OBJECTIVE: The last decade has witnessed an increased number of stand-alone interventional cardiology units due to the consolidation of cardiac surgery services. We aimed to explore the impact of a heart team on the midterm outcomes of patients with...

Cite
Ram E, Raanani E, Klempfner R, et al. Midterm outcomes of patients with multivessel disease treated at centers with and without on-site cardiac surgery services. J Thorac Cardiovasc Surg. 2020;doi: 10.1016/j.jtcvs.2020.04.170.
Ram, E., Raanani, E., Klempfner, R., Peled, Y., Sternik, L., & Segev, A. (2020). Midterm outcomes of patients with multivessel disease treated at centers with and without on-site cardiac surgery services. The Journal of thoracic and cardiovascular surgery, . https://doi.org/10.1016/j.jtcvs.2020.04.170
Ram, Eilon, et al. "Midterm outcomes of patients with multivessel disease treated at centers with and without on-site cardiac surgery services." The Journal of thoracic and cardiovascular surgery vol. (2020). doi: https://doi.org/10.1016/j.jtcvs.2020.04.170
Ram E, Raanani E, Klempfner R, Peled Y, Sternik L, Segev A. Midterm outcomes of patients with multivessel disease treated at centers with and without on-site cardiac surgery services. J Thorac Cardiovasc Surg. 2020 May 30; doi: 10.1016/j.jtcvs.2020.04.170. Epub 2020 May 30. PMID: 32711976.
Copy Download .nbib Format: NLM
Cardiorespiratory fitness and survival following cancer diagnosis.

European journal of preventive cardiology

Fardman A, Banschick GD, Rabia R, Percik R, Fourey D, Segev S, Klempfner R, Grossman E, Maor E.
PMID: 32686470
Eur J Prev Cardiol. 2020 Jul 19;2047487320930873. doi: 10.1177/2047487320930873. Epub 2020 Jul 19.

AIMS: Data on the association of cardiorespiratory fitness with survival of cancer patients are limited. This study aimed to evaluate the association between midlife cardiorespiratory fitness and survival after a subsequent cancer diagnosis.METHODS: We evaluated 19,134 asymptomatic self-referred adults...

Cite
Fardman A, Banschick GD, Rabia R, et al. Cardiorespiratory fitness and survival following cancer diagnosis. Eur J Prev Cardiol. 2020;2047487320930873doi: 10.1177/2047487320930873.
Fardman, A., Banschick, G. D., Rabia, R., Percik, R., Fourey, D., Segev, S., Klempfner, R., Grossman, E., & Maor, E. (2020). Cardiorespiratory fitness and survival following cancer diagnosis. European journal of preventive cardiology, 2047487320930873. https://doi.org/10.1177/2047487320930873
Fardman, Alexander, et al. "Cardiorespiratory fitness and survival following cancer diagnosis." European journal of preventive cardiology vol. (2020): 2047487320930873. doi: https://doi.org/10.1177/2047487320930873
Fardman A, Banschick GD, Rabia R, Percik R, Fourey D, Segev S, Klempfner R, Grossman E, Maor E. Cardiorespiratory fitness and survival following cancer diagnosis. Eur J Prev Cardiol. 2020 Jul 19;2047487320930873. doi: 10.1177/2047487320930873. Epub 2020 Jul 19. PMID: 32686470.
Copy Download .nbib Format: NLM
Disease evolution and risk-based disease trajectories in congestive heart failure patients.

Journal of biomedical informatics

Roni RG, Tsipi H, Ofir BA, Nir S, Robert K.
PMID: 34875386
J Biomed Inform. 2021 Dec 05;125:103949. doi: 10.1016/j.jbi.2021.103949. Epub 2021 Dec 05.

Congestive Heart Failure (CHF) is among the most prevalent chronic diseases worldwide, and is commonly associated with comorbidities and complex health conditions. Consequently, CHF patients are typically hospitalized frequently, and are at a high risk of premature death. Early...

Cite
Roni RG, Tsipi H, Ofir BA, et al. Disease evolution and risk-based disease trajectories in congestive heart failure patients. J Biomed Inform. 2021;125:103949doi: 10.1016/j.jbi.2021.103949.
Roni, R. G., Tsipi, H., Ofir, B. A., Nir, S., & Robert, K. (2021). Disease evolution and risk-based disease trajectories in congestive heart failure patients. Journal of biomedical informatics, 125103949. https://doi.org/10.1016/j.jbi.2021.103949
Roni, Ramon-Gonen, et al. "Disease evolution and risk-based disease trajectories in congestive heart failure patients." Journal of biomedical informatics vol. 125 (2021): 103949. doi: https://doi.org/10.1016/j.jbi.2021.103949
Roni RG, Tsipi H, Ofir BA, Nir S, Robert K. Disease evolution and risk-based disease trajectories in congestive heart failure patients. J Biomed Inform. 2021 Dec 05;125:103949. doi: 10.1016/j.jbi.2021.103949. Epub 2021 Dec 05. PMID: 34875386.
Copy Download .nbib Format: NLM
Disease evolution and risk-based disease trajectories in congestive heart failure patients.

Journal of biomedical informatics

Roni RG, Tsipi H, Ofir BA, Nir S, Robert K.
PMID: 34875386
J Biomed Inform. 2021 Dec 05;125:103949. doi: 10.1016/j.jbi.2021.103949. Epub 2021 Dec 05.

Congestive Heart Failure (CHF) is among the most prevalent chronic diseases worldwide, and is commonly associated with comorbidities and complex health conditions. Consequently, CHF patients are typically hospitalized frequently, and are at a high risk of premature death. Early...

Cite
Roni RG, Tsipi H, Ofir BA, et al. Disease evolution and risk-based disease trajectories in congestive heart failure patients. J Biomed Inform. 2021;125:103949doi: 10.1016/j.jbi.2021.103949.
Roni, R. G., Tsipi, H., Ofir, B. A., Nir, S., & Robert, K. (2021). Disease evolution and risk-based disease trajectories in congestive heart failure patients. Journal of biomedical informatics, 125103949. https://doi.org/10.1016/j.jbi.2021.103949
Roni, Ramon-Gonen, et al. "Disease evolution and risk-based disease trajectories in congestive heart failure patients." Journal of biomedical informatics vol. 125 (2021): 103949. doi: https://doi.org/10.1016/j.jbi.2021.103949
Roni RG, Tsipi H, Ofir BA, Nir S, Robert K. Disease evolution and risk-based disease trajectories in congestive heart failure patients. J Biomed Inform. 2021 Dec 05;125:103949. doi: 10.1016/j.jbi.2021.103949. Epub 2021 Dec 05. PMID: 34875386.
Copy Download .nbib Format: NLM
The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

European journal of gastroenterology & hepatology

Davidov-Derevynko Y, Ben Yakov G, Wieder A, Segal G, Naveh L, Orlova N, Gringauz I, Amit S, Mor O, Klempfner R, Rahav G, Ben Ari Z.
PMID: 33653988
Eur J Gastroenterol Hepatol. 2021 Feb 26; doi: 10.1097/MEG.0000000000002048. Epub 2021 Feb 26.

BACKGROUND: The ongoing outbreak of COVID-19 is associated with higher levels of morbidity and mortality among patients with comorbidities, including the metabolic syndrome. Liver impairment has been reported in up to 54% of hospitalized patients with COVID-19. The impact...

Cite
Davidov-Derevynko Y, Ben Yakov G, Wieder A, et al. The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Eur J Gastroenterol Hepatol. 2021;doi: 10.1097/MEG.0000000000002048.
Davidov-Derevynko, Y., Ben Yakov, G., Wieder, A., Segal, G., Naveh, L., Orlova, N., Gringauz, I., Amit, S., Mor, O., Klempfner, R., Rahav, G., & Ben Ari, Z. (2021). The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. European journal of gastroenterology & hepatology, . https://doi.org/10.1097/MEG.0000000000002048
Davidov-Derevynko, Yana, et al. "The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection." European journal of gastroenterology & hepatology vol. (2021). doi: https://doi.org/10.1097/MEG.0000000000002048
Davidov-Derevynko Y, Ben Yakov G, Wieder A, Segal G, Naveh L, Orlova N, Gringauz I, Amit S, Mor O, Klempfner R, Rahav G, Ben Ari Z. The liver in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Eur J Gastroenterol Hepatol. 2021 Feb 26; doi: 10.1097/MEG.0000000000002048. Epub 2021 Feb 26. PMID: 33653988.
Copy Download .nbib Format: NLM
The Association of Moderate Aortic Stenosis with Poor Survival is Modified by Age and Left Ventricular Function.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

Itelman E, Vatury O, Kuperstein R, Ben-Zekry S, Fefer P, Barbash I, Klempfner R, Segev A, Feinberg M, Guetta V, Maor E.
PMID: 34915134
J Am Soc Echocardiogr. 2021 Dec 13; doi: 10.1016/j.echo.2021.12.002. Epub 2021 Dec 13.

BACKGROUND: Data on the independent association of moderate aortic stenosis (AS) with excess mortality, even when it does not progress to severe AS, is limited.OBJECTIVE: To evaluate the association of moderate AS with poor survival and to identify clinically...

Cite
Itelman E, Vatury O, Kuperstein R, et al. The Association of Moderate Aortic Stenosis with Poor Survival is Modified by Age and Left Ventricular Function. J Am Soc Echocardiogr. 2021;doi: 10.1016/j.echo.2021.12.002.
Itelman, E., Vatury, O., Kuperstein, R., Ben-Zekry, S., Fefer, P., Barbash, I., Klempfner, R., Segev, A., Feinberg, M., Guetta, V., & Maor, E. (2021). The Association of Moderate Aortic Stenosis with Poor Survival is Modified by Age and Left Ventricular Function. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, . https://doi.org/10.1016/j.echo.2021.12.002
Itelman, Edward, et al. "The Association of Moderate Aortic Stenosis with Poor Survival is Modified by Age and Left Ventricular Function." Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography vol. (2021). doi: https://doi.org/10.1016/j.echo.2021.12.002
Itelman E, Vatury O, Kuperstein R, Ben-Zekry S, Fefer P, Barbash I, Klempfner R, Segev A, Feinberg M, Guetta V, Maor E. The Association of Moderate Aortic Stenosis with Poor Survival is Modified by Age and Left Ventricular Function. J Am Soc Echocardiogr. 2021 Dec 13; doi: 10.1016/j.echo.2021.12.002. Epub 2021 Dec 13. PMID: 34915134.
Copy Download .nbib Format: NLM
Disease evolution and risk-based disease trajectories in congestive heart failure patients.

Journal of biomedical informatics

Roni RG, Tsipi H, Ofir BA, Nir S, Robert K.
PMID: 34875386
J Biomed Inform. 2021 Dec 05;125:103949. doi: 10.1016/j.jbi.2021.103949. Epub 2021 Dec 05.

Congestive Heart Failure (CHF) is among the most prevalent chronic diseases worldwide, and is commonly associated with comorbidities and complex health conditions. Consequently, CHF patients are typically hospitalized frequently, and are at a high risk of premature death. Early...

Cite
Roni RG, Tsipi H, Ofir BA, et al. Disease evolution and risk-based disease trajectories in congestive heart failure patients. J Biomed Inform. 2021;125:103949doi: 10.1016/j.jbi.2021.103949.
Roni, R. G., Tsipi, H., Ofir, B. A., Nir, S., & Robert, K. (2021). Disease evolution and risk-based disease trajectories in congestive heart failure patients. Journal of biomedical informatics, 125103949. https://doi.org/10.1016/j.jbi.2021.103949
Roni, Ramon-Gonen, et al. "Disease evolution and risk-based disease trajectories in congestive heart failure patients." Journal of biomedical informatics vol. 125 (2021): 103949. doi: https://doi.org/10.1016/j.jbi.2021.103949
Roni RG, Tsipi H, Ofir BA, Nir S, Robert K. Disease evolution and risk-based disease trajectories in congestive heart failure patients. J Biomed Inform. 2021 Dec 05;125:103949. doi: 10.1016/j.jbi.2021.103949. Epub 2021 Dec 05. PMID: 34875386.
Copy Download .nbib Format: NLM
A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer.

JAMA network open

Anderson E, LeVee A, Kim S, Atkins K, Guan M, Placencio-Hickok V, Moshayedi N, Hendifar A, Osipov A, Gangi A, Burch M, Waters K, Cho M, Klempner S, Chao J, Kamrava M, Gong J.
PMID: 34889947
JAMA Netw Open. 2021 Dec 01;4(12):e2138432. doi: 10.1001/jamanetworkopen.2021.38432.

IMPORTANCE: Treatment of resectable gastric cancer (RGC) uses a multimodal approach, including surgical treatment and chemotherapy with or without radiation therapy, and the optimal treatment strategy and timing of each of these modalities is unknown.OBJECTIVE: To investigate the association...

Cite
Anderson E, LeVee A, Kim S, et al. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. JAMA Netw Open. 2021;4(12):e2138432doi: 10.1001/jamanetworkopen.2021.38432.
Anderson, E., LeVee, A., Kim, S., Atkins, K., Guan, M., Placencio-Hickok, V., Moshayedi, N., Hendifar, A., Osipov, A., Gangi, A., Burch, M., Waters, K., Cho, M., Klempner, S., Chao, J., Kamrava, M., & Gong, J. (2021). A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. JAMA network open, 4(12), e2138432. https://doi.org/10.1001/jamanetworkopen.2021.38432
Anderson, Eric, et al. "A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer." JAMA network open vol. 4,12 (2021): e2138432. doi: https://doi.org/10.1001/jamanetworkopen.2021.38432
Anderson E, LeVee A, Kim S, Atkins K, Guan M, Placencio-Hickok V, Moshayedi N, Hendifar A, Osipov A, Gangi A, Burch M, Waters K, Cho M, Klempner S, Chao J, Kamrava M, Gong J. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. JAMA Netw Open. 2021 Dec 01;4(12):e2138432. doi: 10.1001/jamanetworkopen.2021.38432. PMID: 34889947.
Copy Download .nbib Format: NLM
Association of Polycythemia with Outcomes of Acute Coronary Syndrome.

Cardiology

Marcus G, Farkouh ME, Minha S, Fuchs S, Kalmanovich E, Beigel R, Iakobishvili Z, Klempfner R, Matezky S, Marcus R.
PMID: 34718235
Cardiology. 2021;146(6):720-727. doi: 10.1159/000519468. Epub 2021 Oct 29.

BACKGROUND: Polycythemia has not been extensively studied for its impact on acute coronary syndrome (ACS) outcomes. A previous study reported only 30-day outcomes to be worse in these patients.METHODS: Data from the ACS Israeli survey between 2000 and 2018...

Cite
Marcus G, Farkouh ME, Minha S, et al. Association of Polycythemia with Outcomes of Acute Coronary Syndrome. Cardiology. 2021;146(6):720-727doi: 10.1159/000519468.
Marcus, G., Farkouh, M. E., Minha, S., Fuchs, S., Kalmanovich, E., Beigel, R., Iakobishvili, Z., Klempfner, R., Matezky, S., & Marcus, R. (2021). Association of Polycythemia with Outcomes of Acute Coronary Syndrome. Cardiology, 146(6), 720-727. https://doi.org/10.1159/000519468
Marcus, Gil, et al. "Association of Polycythemia with Outcomes of Acute Coronary Syndrome." Cardiology vol. 146,6 (2021): 720-727. doi: https://doi.org/10.1159/000519468
Marcus G, Farkouh ME, Minha S, Fuchs S, Kalmanovich E, Beigel R, Iakobishvili Z, Klempfner R, Matezky S, Marcus R. Association of Polycythemia with Outcomes of Acute Coronary Syndrome. Cardiology. 2021;146(6):720-727. doi: 10.1159/000519468. Epub 2021 Oct 29. PMID: 34718235.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 37 entries